Recombinant Human CA5A Protein (HEK293)

CA5A, or Carbonic Anhydrase 5A, is an enzyme belonging to the carbonic anhydrase family, which plays a crucial role in maintaining acid-base balance and facilitating carbon dioxide transport in the body. Research into CA5A has gained significant attention due to its potential implications in various physiological and pathological processes, including metabolism, respiration, and neurodegenerative diseases. With its unique catalytic properties, CA5A is involved in the hydration of carbon dioxide to bicarbonate and protons, a reaction vital for cellular functions and signaling pathways. Studies have shown that alterations in CA5A activity can be linked to disorders such as myopathies, respiratory insufficiencies, and certain types of cancers. Furthermore, its presence in specific tissues and its differential expression highlight its importance in certain biological contexts, prompting investigations into its roles in both health and disease. Understanding the structure-function relationships of CA5A and its regulatory mechanisms could pave the way for innovative therapeutic strategies, making it a promising target for drug development. Additionally, recombinant expression systems are being employed to produce CA5A for biochemical characterization and functional assays, allowing researchers to explore its potential applications in biotechnology and medicine. Overall, the study of CA5A represents a multidisciplinary approach, merging biochemistry, molecular biology, and clinical research, and holds promise for advancing our understanding of its biological significance and therapeutic potential.